Front Row Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-236
Closed -$23K 510
2024
Q2
$23K Sell
236
-12
-5% -$1.43K 0.01% 391
2024
Q1
$32.8K Buy
+248
New +$30.5K 0.01% 310
2023
Q4
Sell
-247
Closed -$42.1K 483
2023
Q3
$42.1K Buy
247
+2
+0.8% +$398 0.02% 255
2023
Q2
$55K Sell
245
-11
-4% -$2.25K 0.02% 237
2023
Q1
$57K Sell
256
-3
-1% -$739 0.03% 235
2022
Q4
$56K Hold
259
0.03% 230
2022
Q3
$69K Buy
259
+6
+2% +$1.53K 0.04% 208
2022
Q2
$53K Hold
253
0.03% 246
2022
Q1
$56K Sell
253
-1
-0.4% -$211 0.02% 247
2021
Q4
$59K Sell
254
-14
-5% -$3.46K 0.02% 250
2021
Q3
$59K Hold
268
0.02% 247
2021
Q2
$57K Sell
268
-8
-3% -$1.29K 0.02% 255
2021
Q1
$40K Sell
276
-3
-1% -$481 0.02% 283
2020
Q4
$41K Hold
279
0.02% 275
2020
Q3
$38K Sell
279
-2
-0.7% -$177 0.02% 277
2020
Q2
$22K Sell
281
-7
-2% -$476 0.01% 325
2020
Q1
$18K Hold
288
0.01% 348
2019
Q4
$21K Hold
288
0.01% 323
2019
Q3
$20K Sell
288
-2
-0.7% -$136 0.01% 322
2019
Q2
$21K Hold
290
0.02% 310
2019
Q1
$24K Buy
290
+239
+469% +$19.5K 0.02% 283
2018
Q4
$4K Sell
51
-246
-83% -$23.2K ﹤0.01% 574
2018
Q3
$28 Buy
+297
New +$28.7K 0.02% 258

Other funds holding ALB

Front Row Advisors's ALB Position: Q3 2024 in Review

Front Row Advisors sold out of Albemarle (ALB) in Q3 2024, closing a stake of 236 shares — an estimated $23K sold.

Front Row Advisors first reported a position in ALB in Q3 2018 and held it in 23 quarters. The position peaked at $69K in Q3 2022. 802 funds tracked by Wall St. Rank hold ALB as of Q3 2024.

  • Front Row Advisors reported no remaining Albemarle position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 236 Albemarle shares in Q3 2024, an estimated $23K.
  • Front Row Advisors first reported a position in Albemarle in Q3 2018 and held it in 23 quarters.
  • Front Row Advisors's Albemarle position peaked at $69K in Q3 2022.
  • 802 funds tracked by Wall St. Rank held Albemarle as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.